[1] Pirinen E, Auranen M, Khan NA, et al. Niacin Cures Systemic NAD+ Deficiency and Improves Muscle Performance in Adult-Onset Mitochondrial Myopathy. Cell Metab. 2020 Jul 7;32(1):144.
[2] Cerutti, R., Pirinen, E., Lamperti, C., et al. NAD+-dependent activationof Sirt1 corrects the phenotype in a mouse model of mitochondrial disease. Cell Metab. 2014, 19, 1042–1049.
[3] Guyton, J.R., and Bays, H.E. Safety considerations with niacin therapy. Am. J. Cardiol. 2007,99, 22C–31C.
[4] Yoshino Jun, Mills Kathryn F, Yoon Myeong Jin et al. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice.[J] .Cell Metab, 2011, 14: 528-36.